Monday 5 December 2022
- Advertisement -

Tag: mutation

Covishield produces more antibodies with higher seropositivity rate than Covaxin

The study said that both vaccines-- Covishield and Covaxin-- elicited a good response after two doses, but seropositivity rate and median anti-spike antibody were significantly higher in Covishield

Covaxin effective against mutated coronavirus, study shows

Harsh Vardhan had explained that Covaxin is more likely to work against newer variants like the variant and the double mutation

कोरोनावायरस की तीसरी लहर भी आएगी, सरकार ने किया सावधान

वैक्‍सीन कोरोनावायरस के मौजूदा वैरिएंट के ख़िलाफ़ कामयाब है पर दुनियाभर में वायरस के नए वैरिएंट्स सामने आएंगे—सरकार के प्रधान वैज्ञानिक सलाहकार

Covaxin neutralises B.1.617 Covid-19 mutant: US medical adviser

Covaxin was developed by Bharat Biotech in partnership with National Institute of Virology and the ICMR and was approved for emergency use on 3 January while still in clinical trial
[prisna-google-website-translator]